All journal publications (1963-2013)
Filters: author is Kraus [Clear All Filters]
- 2012
- 2011
The HIV protease inhibitor Nelfinavir has proteasome-inhibiting activity in vivo distinct from Bortezomib,
Onkologie, vol. 34, pp. 159-159.
- 2009
Syringolin A Selectively Labels the 20 S Proteasome in Murine EL4 and Wild-Type and Bortezomib-Adapted Leukaemic Cell Lines,
Chembiochem, vol. 10, no. 16, pp. 2638-2643. DOI
Characterization of the ubiquitin-proteasome system in bortezomib-adapted cells,
Leukemia, vol. 23, no. 6, pp. 1098-1105. DOI
- 2008
Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation,
European Journal of Immunology, vol. 38, no. 9, pp. 2401-2411. DOI
Ritonavir induces endoplasmic reticulum stress and sensitizes sarcoma cells toward bortezomib-induced apoptosis,
Molecular Cancer Therapeutics, vol. 7, no. 7, pp. 1940-1948. DOI
- 2007
Activity patterns of proteasome subunits reflect bortezomib sensitivity of hematologic malignancies and are variable in primary human leukemia cells,
Leukemia, vol. 21, no. 1, pp. 84-92.
Endocytosis targets exogenous material selectively to cathepsin S in live human dendritic cells, while cellpenetrating peptides mediate nonselective transport to cysteine cathepsins,
Journal of Leukocyte Biology, vol. 81, no. 4, pp. 990-1001. DOI
- 2005
Differential processing of autoantigens in lysosomes from human monocyte-derived and peripheral blood dendritic cells,
Journal of Immunology, vol. 175, no. 9, pp. 5940-5949.
Probing the potential of platinum(II) complexes for the inhibition of thiol-dependent enzymatic activity,
Journal of Inorganic Biochemistry, vol. 99, no. 6, pp. 1384-1389.
- 2004
Human B lymphoblastoid cells contain distinct patterns of cathepsin activity in endocytic compartments and regulate MHC class II transport in a cathepsin S-independent manner,
Journal of Leukocyte Biology, vol. 75, no. 5, pp. 844-855.


